The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United States and Mexico.
Search / 9 results found Showing: 9 of 9
A common cold virus called respiratory syncytial virus (RSV) is spreading across the South, causing an unusual wave of late spring disease, the US Centers for Disease Control and prevention said Thursday.
When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted smiley face emojis to a journalist seeking his reaction.
Johnson & Johnson's Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% efficacy against severe disease, the company announced Friday.
SPRINGFIELD, MA (WGGB/WSHM) -- A cholesterol drug that's been around for years is now being tested as a possible treatment to fight COVID-19.
Health care systems in many places struggle in winter. Conditions such as asthma, heart attacks and stroke tend to worsen in colder temperatures, and some infectious diseases like influenza spread more easily, which means facilities face a greater patient load.
WEST SPRINGFIELD, MA (WGGB/WSHM) -- Coronavirus can appear similar to other illnesses such as the common cold or flu, but as we get into sprin…
SPRINGFIELD, MA (WGGB/WSHM) -- Mercy Medical Center in Springfield confirms to Western Mass News, several patients have recently been placed i…
An Iowa family is warning parents after what they thought was the common cold turned into a mysterious polio-like disease in their 3-year-old son.